全文获取类型
收费全文 | 303799篇 |
免费 | 25627篇 |
国内免费 | 9204篇 |
专业分类
耳鼻咽喉 | 3587篇 |
儿科学 | 6435篇 |
妇产科学 | 4345篇 |
基础医学 | 24302篇 |
口腔科学 | 8166篇 |
临床医学 | 27843篇 |
内科学 | 40922篇 |
皮肤病学 | 2946篇 |
神经病学 | 13193篇 |
特种医学 | 8957篇 |
外国民族医学 | 33篇 |
外科学 | 31831篇 |
综合类 | 50755篇 |
现状与发展 | 28篇 |
一般理论 | 28篇 |
预防医学 | 34738篇 |
眼科学 | 2890篇 |
药学 | 29162篇 |
454篇 | |
中国医学 | 34202篇 |
肿瘤学 | 13813篇 |
出版年
2024年 | 1235篇 |
2023年 | 5972篇 |
2022年 | 10964篇 |
2021年 | 14266篇 |
2020年 | 13894篇 |
2019年 | 14843篇 |
2018年 | 13364篇 |
2017年 | 12026篇 |
2016年 | 11422篇 |
2015年 | 10545篇 |
2014年 | 20219篇 |
2013年 | 20243篇 |
2012年 | 17914篇 |
2011年 | 19833篇 |
2010年 | 16317篇 |
2009年 | 13939篇 |
2008年 | 13093篇 |
2007年 | 13399篇 |
2006年 | 11957篇 |
2005年 | 10062篇 |
2004年 | 8203篇 |
2003年 | 7221篇 |
2002年 | 5706篇 |
2001年 | 4908篇 |
2000年 | 4247篇 |
1999年 | 3515篇 |
1998年 | 2977篇 |
1997年 | 2672篇 |
1996年 | 2247篇 |
1995年 | 2137篇 |
1994年 | 1961篇 |
1993年 | 1664篇 |
1992年 | 1541篇 |
1991年 | 1360篇 |
1990年 | 1196篇 |
1989年 | 1129篇 |
1988年 | 1060篇 |
1987年 | 930篇 |
1986年 | 857篇 |
1985年 | 2285篇 |
1984年 | 2563篇 |
1983年 | 1642篇 |
1982年 | 2130篇 |
1981年 | 1562篇 |
1980年 | 1386篇 |
1979年 | 1243篇 |
1978年 | 1032篇 |
1977年 | 815篇 |
1976年 | 905篇 |
1975年 | 594篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
2.
《Journal of pediatric surgery》2023,58(5):856-861
Background/PurposeA small number of Hirschsprung disease (HD) patients develop inflammatory bowel disease (IBD)-like symptoms after pullthrough surgery. The etiology and pathophysiology of Hirschsprung-associated IBD (HD-IBD) remains unknown. This study aims to further characterize HD-IBD, to identify potential risk factors and to evaluate response to treatment in a large group of patients.MethodsRetrospective study of patients diagnosed with IBD after pullthrough surgery between 2000 and 2021 at 17 institutions. Data regarding clinical presentation and course of HD and IBD were reviewed. Effectiveness of medical therapy for IBD was recorded using a Likert scale.ResultsThere were 55 patients (78% male). 50% (n = 28) had long segment disease. Hirschsprung-associated enterocolitis (HAEC) was reported in 68% (n = 36). Ten patients (18%) had Trisomy 21. IBD was diagnosed after age 5 in 63% (n = 34). IBD presentation consisted of colonic or small bowel inflammation resembling IBD in 69% (n = 38), unexplained or persistent fistula in 18% (n = 10) and unexplained HAEC >5 years old or unresponsive to standard treatment in 13% (n = 7). Biological agents were the most effective (80%) medications. A third of patients required a surgical procedure for IBD.ConclusionMore than half of the patients were diagnosed with HD-IBD after 5 years old. Long segment disease, HAEC after pull through operation and trisomy 21 may represent risk factors for this condition. Investigation for possible IBD should be considered in children with unexplained fistulae, HAEC beyond the age of 5 or unresponsive to standard therapy, and symptoms suggestive of IBD. Biological agents were the most effective medical treatment.Level of EvidenceLevel 4 相似文献
3.
4.
5.
穴位埋线是长效针灸,是在传统针具和针法基础上建立和发展起来的,是针灸技术的发展和延伸,穴位埋线的核心技术是穿刺技术,穴位埋线的三大要素中,针具、埋藏物、穿刺技巧之间是互相影响、互相促进的。针具的改进成功实现了穴位埋线疗法的第一次飞跃,埋藏物的改进成功实现了穴位埋线疗法的第二次飞跃,穿刺技术的改进和创新是穴位埋线疗法的第三次飞跃。 相似文献
6.
通过对中医古籍中有关升降散论述的文献梳理,全面探讨其内涵。本方是在大黄、僵蚕为雏形的基础上增加蝉蜕、姜黄而成方,几经易名,终在杨璿《伤寒瘟疫条辨》中为后人所熟知。本方广泛用于治疗瘟疫,以丸剂、散剂为主,方便携带,便于服用;重用大黄旨在祛邪、逐秽;应用时视人之体质强弱和量其毒之轻重而判断用药多寡,并辅以米酒、生蜜等以顾护正气。杨璿将其由治疗“热疫”的专方扩展为治疗“表里三焦大热”的通用方剂,扩大了本方治疗疾病范围。 相似文献
7.
严桂英 《中国卫生标准管理》2020,(8):95-98
目的探究益气养精法对老年肺癌患者肿瘤标志物、生存期影响。方法研究纳入60例老年肺癌患者,均由本院2016年1月-2017年1月收治,采取随机数字表法将患者分为两组,对照组患者(30例)常规化疗治疗,观察组患者(30例)在化疗基础上联合益气养精法治疗,比较两组患者治疗效果、治疗前后癌胚抗原(carcino-embryonic antigen,CEA)及血清癌抗原125(serum oncoantigen 125,CA 125)肿瘤标志物水平、不良反应情况及患者2年生存率。结果观察组患治疗有效率高于对照组,P<0.05;治疗前,两组患者CEA及CA 125水平相当,P>0.05,治疗后均改善,观察组优于对照组,P<0.05;观察组患者不良反应与对照组相当,均较低,P>0.05;观察组患者2年生存率高于对照组,P<0.05。结论益气养精法治疗老年肺癌患者效果患者,患者症状改善,不良反应少,安全可靠,且患者2年生存率较高。 相似文献
8.
B Maybury A Powell-Chandler N Kumar 《Annals of the Royal College of Surgeons of England》2015,97(3):e37-e38
We report two British cases of liver abscess, due to Klebsiella pneumoniae and associated with synchronous infection elsewhere, which required liver resection for definitive treatment. They illustrate the geographic spread of aggressive K pneumoniae liver infection and demonstrate the importance of early aggressive treatment. 相似文献
9.
10.
《Archives of Cardiovascular Diseases》2022,115(10):505-513
Central illustration: cumulative major adverse cardiac events (MACE) and bioresorbable vascular scaffold (BVS) thrombosis rates after 1, 2, 3, 4 and 5 years. 相似文献